Just read this, which sounds very encouraging, and thought the rest of you would be interested too!
practiceupdate.com/c/45003/...
It's about the results of a trial involving the PARP inhibitor niraparib, which appears to have had good results both in women with BRCA mutations and those without BRCA mutations.
You may have to sign up to read the article, but signing up is free.
Barbara